Comments

Greenwich LifeSciences

GLSINASDAQ
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$15.55
-0.49-3.05%
At Close: -
$15.55
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Greenwich LifeSciences (GLSI) ForecastNewsEarningsGuidanceDividendsAnalyst Ratings

Insider Trades

Short Interest

Greenwich LifeSciences (NASDAQ:GLSI) Stock, Insider Trading Activity

Greenwich LifeSciences: Insider buying and selling updated today.

What is Insider Activity?

Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.

What are Greenwich LifeSciences Inc Insiders Doing?

At Greenwich LifeSciences Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have report no sales in the last 30 days, meanwhile, insiders have reported buying a total of 2.50K shares for a total value of $39.84K.

Notable Recent Insider Buys and Sales

  • On June 17, 2024, Snehal Patel, the company's CEO AND CFO purchased 174.83K shares for $14.3 each.
  • On July 24, 2024, Snehal Patel, the company's CEO AND CFO purchased 1.5K shares for $15.89 each.
  • On July 22, 2024, Jaye Thompson, the company's VP CLINICAL REG AFFAIRS purchased 1K shares for $16 each.

Ownership Statistics for Greenwich LifeSciences Inc

Institutional Shares Held
821.855K
Institutional Percentage Held
6.38%
Jul 24, 2024Snehal PatelCEO AND CFO1.50K$15.89$23.84KBUY0.03%5.53MJul 23View
Jul 22, 2024Jaye ThompsonVP CLINICAL REG AFFAIRS1.00K$16.00$16.00KBUY0.38%261.35KJul 18View
Jun 17, 2024Snehal PatelCEO AND CFO174.82K$14.30$2.50MBUY3.27%5.53MJun 13View
Apr 03, 2024Snehal PatelCEO AND CFO3.00K$19.08$57.24KBUY0.06%5.35MApr 01View
Mar 26, 2024Snehal PatelCEO AND CFO2.50K$19.98$49.95KBUY0.05%5.35MMar 22View
Mar 22, 2024Snehal PatelCEO AND CFO1.50K$17.68$26.52KBUY0.03%5.35MMar 20View
Mar 07, 2024Snehal PatelCEO AND CFO30.50K$12.49$380.94KBUY0.57%5.34MMar 05View
Mar 06, 2024Snehal PatelCEO AND CFO4.10K$13.03$53.42KBUY0.08%5.34MMar 04View
Feb 21, 2024Snehal PatelCEO AND CFO10.80K$11.16$120.53KBUY0.20%5.34MFeb 16View
Feb 20, 2024Snehal PatelCEO AND CFO12.70K$11.07$140.59KBUY0.24%5.33MFeb 15View
Nov 14, 2023Snehal PatelCEO AND CFO5.00K$10.17$50.84KBUY0.09%5.31MNov 10View
Nov 07, 2023Snehal PatelCEO AND CFO3.50K$9.11$31.88KBUY0.07%5.31MNov 03View
Oct 31, 2023Jaye ThompsonVP CLINICAL REG AFFAIRS500.00$8.57$4.29KBUY0.19%260.35KOct 27View
Oct 30, 2023Snehal PatelCEO AND CFO2.50K$7.97$19.93KBUY0.05%5.30MOct 26View
Oct 27, 2023Snehal PatelCEO AND CFO2.50K$7.91$19.77KBUY0.05%5.30MOct 25View
Oct 12, 2023Snehal PatelCEO AND CFO1.00K$9.07$9.07KBUY0.02%5.30MOct 10View
Oct 05, 2023Snehal PatelCEO AND CFO2.00K$8.63$17.26KBUY0.04%5.30MOct 04View
Sep 28, 2023Jaye ThompsonVP CLINICAL REG AFFAIRS600.00$8.71$5.23KBUY0.23%259.85KSep 26View
Sep 21, 2023Snehal PatelCEO AND CFO4.00K$8.95$35.80KBUY0.08%5.30MSep 19View
Sep 13, 2023Snehal PatelCEO AND CFO1.00K$9.48$9.48KBUY0.02%5.29MSep 11View
Aug 24, 2023Snehal PatelCEO AND CFO1.00K$9.97$9.97KBUY0.02%5.29MAug 22View
Aug 08, 2023Snehal PatelCEO AND CFO2.00K$10.55$21.10KBUY0.04%5.29MAug 04View
Jul 25, 2023Snehal PatelCEO AND CFO1.00K$9.20$9.20KBUY0.02%5.29MJul 21View
Jul 17, 2023Jaye ThompsonVP CLINICAL REG AFFAIRS250.00$9.49$2.37KBUY0.10%259.25KJul 13View
May 18, 2023Snehal PatelCEO AND CFO1.00K$11.69$11.69KBUY0.02%5.29MMay 17View
May 02, 2023Jaye ThompsonVP CLINICAL REG AFFAIRS250.00$11.22$2.81KBUY0.10%259.00KApr 28View
Apr 21, 2023Snehal PatelCEO AND CFO7.00K$11.10$77.70KBUY0.13%5.29MApr 19View
Apr 20, 2023Snehal PatelCEO AND CFO2.00K$11.12$22.24KBUY0.04%5.28MApr 18View
Apr 12, 2023Jaye ThompsonVP CLINICAL REG AFFAIRS1.00K$11.87$11.87KBUY0.39%258.75KApr 11View
Apr 12, 2023Snehal PatelCEO AND CFO5.00K$12.42$62.10KBUY0.09%5.27MApr 11View
Mar 16, 2023Jaye ThompsonVP CLINICAL REG AFFAIRS250.00$12.71$3.18KBUY0.10%257.75KMar 15View
Mar 13, 2023Snehal PatelCEO AND CFO1.00K$12.12$12.12KBUY0.04%2.74MMar 10View
Feb 28, 2023Jaye ThompsonVP CLINICAL REG AFFAIRS250.00$15.39$3.85KBUY0.10%257.50KFeb 24View
Feb 22, 2023Snehal PatelCEO AND CFO600.00$16.53$9.92KBUY0.02%2.74MFeb 17View
Feb 14, 2023Snehal PatelCEO AND CFO1.00K$18.68$18.68KBUY0.04%2.74MFeb 10View
Feb 07, 2023Jaye ThompsonVP CLINICAL REG AFFAIRS250.00$20.84$5.21KBUY0.10%257.25KFeb 03View
Jan 31, 2023Snehal PatelCEO AND CFO2.00K$19.35$38.70KBUY0.07%2.73MJan 27View
Jan 30, 2023Jaye ThompsonVP CLINICAL REG AFFAIRS250.00$19.20$4.80KBUY0.10%257.00KJan 27View
Jan 24, 2023Snehal PatelCEO AND CFO1.50K$17.37$26.05KBUY0.05%2.73MJan 20View
Jan 17, 2023Jaye ThompsonVP CLINICAL REG AFFAIRS250.00$16.50$4.13KBUY0.10%256.75KJan 13View
Jan 10, 2023Snehal PatelCEO AND CFO1.50K$15.18$22.77KBUY0.05%2.73MJan 06View
Jan 03, 2023Snehal PatelCEO AND CFO4.00K$15.19$60.76KBUY0.15%2.73MDec 29View
Dec 20, 2022Snehal PatelCEO AND CFO1.00K$13.01$13.01KBUY0.04%2.73MDec 16View
Dec 20, 2022Jaye ThompsonVP CLINICAL REG AFFAIRS250.00$12.94$3.23KBUY0.10%256.50KDec 16View
Dec 13, 2022Snehal PatelCEO AND CFO2.00K$13.11$26.22KBUY0.07%2.72MDec 09View
Dec 06, 2022Snehal PatelCEO AND CFO1.00K$13.84$13.84KBUY0.04%2.72MDec 02View
Dec 06, 2022Jaye ThompsonVP CLINICAL REG AFFAIRS250.00$13.98$3.50KBUY0.10%256.25KDec 02View
Nov 04, 2022Snehal PatelCEO AND CFO2.00K$8.79$17.58KBUY0.07%2.72MNov 02View
Oct 17, 2022Snehal PatelCEO AND CFO3.00K$9.75$29.25KBUY0.11%2.72MOct 14View
Oct 11, 2022Snehal PatelCEO AND CFO2.00K$9.72$19.44KBUY0.07%2.72MOct 07View
Oct 04, 2022Snehal PatelCEO AND CFO1.00K$9.46$9.46KBUY0.04%2.71MSep 30View
Oct 03, 2022Snehal PatelCEO AND CFO1.00K$9.23$9.23KBUY0.04%2.71MSep 29View
Jun 27, 2022Snehal PatelCEO AND CFO29.00K$9.13$264.77KBUY1.08%2.71MJun 24View
Jun 17, 2022Snehal PatelCEO AND CFO8.00K$7.13$57.04KBUY0.30%2.68MJun 16View
Jun 15, 2022Snehal PatelCEO AND CFO12.00K$7.91$94.92KBUY0.45%2.68MJun 14View
Jun 13, 2022Snehal PatelCEO AND CFO12.00K$8.33$99.96KBUY0.45%2.66MJun 10View
Jun 10, 2022Snehal PatelCEO AND CFO4.50K$10.90$49.05KBUY0.36%1.24MJun 09View
Jun 08, 2022Snehal PatelCEO AND CFO6.00K$8.55$51.30KBUY0.49%1.24MJun 07View
Jun 06, 2022Snehal PatelCEO AND CFO9.25K$8.35$77.24KBUY0.76%1.23MJun 03View
Jun 03, 2022Snehal PatelCEO AND CFO6.77K$7.38$49.99KBUY0.56%1.22MJun 02View
Apr 26, 2022Frank DaughertyCHIEF MEDICAL OFFICER1.00K$16.25$16.25KBUY1.12%90.12KApr 25View
Apr 22, 2022Snehal PatelCEO AND CFO6.00K$16.09$96.54KBUY0.50%1.22MApr 21View
Apr 21, 2022Snehal PatelCEO AND CFO6.00K$16.74$100.44KBUY0.50%1.21MApr 19View
Apr 20, 2022Jaye ThompsonVP CLINICAL REG AFFAIRS500.00$16.74$8.37KBUY0.20%256.00KApr 19View
Feb 14, 2022Snehal PatelCEO AND CFO5.50K$19.80$108.90KBUY0.46%1.20MFeb 11View
Feb 08, 2022Snehal PatelCEO AND CFO5.00K$19.59$97.95KBUY0.42%1.20MFeb 04View
Feb 01, 2022Jaye ThompsonVP CLINICAL REG AFFAIRS500.00$18.47$9.23KBUY0.20%255.50KJan 31View
Jan 24, 2022Jaye ThompsonVP CLINICAL REG AFFAIRS500.00$16.33$8.16KBUY0.20%255.00KJan 21View
Jan 24, 2022Ken HallockDIRECTOR300.00$16.32$4.90KBUY0.08%397.30KJan 21View
Jan 19, 2022Jaye ThompsonVP CLINICAL REG. AFFAIRS500.00$18.87$9.44KBUY0.20%254.50KJan 18View
Jan 18, 2022Snehal PatelCEO AND CFO1.00K$19.99$19.99KBUY0.08%1.19MJan 13View
Jan 14, 2022Jaye ThompsonVP CLINICAL REG. AFFAIRS1.00K$19.99$19.99KBUY0.40%254.00KJan 13View
Jan 14, 2022Frank DaughertyCHIEF MEDICAL OFFICER1.00K$19.99$19.99KBUY1.13%89.12KJan 13View
Jan 04, 2022Snehal PatelCEO AND CFO2.05K$23.82$48.83KBUY0.17%1.19MJan 03View
Dec 16, 2021Snehal PatelCEO AND CFO1.84K$27.17$49.99KBUY0.15%1.19MDec 14View
Dec 16, 2021Frank DaughertyCHIEF MEDICAL OFFICER1.11K$26.99$29.98KBUY1.28%88.12KDec 14View
Dec 16, 2021David McWilliamsDIRECTOR200.00$27.56$5.51KBUY0.03%620.30KDec 14View
Apr 14, 2021Snehal PatelCEO AND CFO2.70K$36.98$99.85KBUY0.11%2.52MApr 13View
Nov 27, 2020Kenneth Hallock—1.00K$5.39$5.39KPURCHASE0.25%397.00KNov 24View
Nov 25, 2020Frank Daugherty—1.00K$5.10$5.10KPURCHASE1.16%87.01KNov 23View
Nov 24, 2020David McWilliams—1.50K$5.40$8.10KPURCHASE0.24%620.10KNov 20View
Nov 24, 2020Kenneth Hallock—1.00K$5.37$5.37KPURCHASE0.25%396.00KNov 20View
Nov 24, 2020Eric Rothe—2.00K$5.40$10.80KPURCHASE0.64%313.23KNov 20View
Nov 20, 2020Snehal Patel—2.00K$5.40$10.80KPURCHASE0.08%2.52MNov 19View
Oct 01, 2020Snehal Patel—16.67K$4.60$76.71KPURCHASE0.67%2.51MSep 29View
Oct 01, 2020Kenneth Hallock—8.33K$4.60$38.35KPURCHASE2.16%395.00KSep 29View
Sep 29, 2020Kenneth Hallock—74.78K$5.75$430.00KPURCHASE40.96%257.37KSep 29View
Sep 29, 2020Snehal Patel—114.35K$5.75$657.50KPURCHASE15.26%863.68KSep 29View
Sep 29, 2020Joseph Frank Daugherty—1.74K$5.75$10.00KPURCHASE2.06%86.01KSep 29View
Sep 29, 2020David McWilliams—2.61K$5.75$15.00KPURCHASE0.59%446.98KSep 29View

FAQ

Q

Is insider trading legal?

A
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
Q

What are some examples of market manipulation?

A
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.

Browse insider trades on all stocks.

People Also Watch